Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization.

Alexa O LeveyMohammad ElsayedDavid H LawsonRobert M ErmentroutRagini R KudchadkarZachary L BercuMelinda L YushakJanice NewsomeNima Kokabi

Published in: Cardiovascular and interventional radiology (2019)

Concurrent immunotherapy and an ECOG performance status of 0 at the time of Y90 therapy appear to be predictors of prolonged OS and PFS in patients with ocular melanoma metastatic to the liver.

Keyphrases

free survival
squamous cell carcinoma
small cell lung cancer
locally advanced
optic nerve
stem cells
basal cell carcinoma
mesenchymal stem cells
radiation therapy
liver metastases
rectal cancer
cell therapy